Coloplast Stock: Recession-Resilient But Still A Bit Too Expensive (OTCMKTS:CLPBF)

Coloplast's full-year revenue grew and EPS declined slightly. See why the stock is still a bit overvalued and not a good investment currently.

Related Keywords

Denmark ,New York ,United States ,New York Stock Exchange ,Aage Louis Hansen ,Johanne Louis Hansen ,York Stock Exchange ,Atos Medical ,Ostomy Care ,Continence Care ,Interventional Urology ,Skin Care ,Respiratory Care ,Coloplast Conference Call Presentation ,Coloplast Roadshow Presentation Fiscal ,Income Statement Fiscal ,Coloplast Conference Call ,